Purdue Pharma L.p.

Rhodes Technologies

Purdue Pharmaceuticals L.p.

The P.f. Laboratories, Inc.

Euro-Celtique S.a.

Lonn S Rider

Donald Kyle

Robert J Kupper

Qi Hong

Robert Chapman

Joshua Robert Giguere

Donald J Kyle

Stuart James Gebbie

Keith Mccarthy

Joshua R Giguere

Robert Joe Kupper

In certain embodiments the invention is directed to a process for preparing an oxycodone hydrochloride composition having less than 25 ppm of 14-hydroxycodeinone.

Process for preparing oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone

Compounds and compositions for use as starting materials or intermediate materials in the preparation of opioids including, e.g., oxycodone base and/or an oxycodone salt; processes for preparing these compounds and compositions; uses of these compounds and compositions in the preparation of APIs and pharmaceutical dosage forms; and uses of said APIs and pharmaceutical dosage forms in the treatment of medical conditions.

Process for improved opioid synthesis

Process for preparing oxycodone hydrochloride having less than 25 PPM 14-hydroxycodeinone

Process for preparing oxycodone compositions

Compounds and compositions for use as starting materials or intermediate materials in the preparation of opioids including, e.g., oxymorphone base and/or an oxymorphone salt; processes for preparing these compounds and compositions; uses of these compounds and compositions in the preparation of APIs and pharmaceutical dosage forms; and uses of said APIs and pharmaceutical dosage forms in the treatment of medical conditions.

Growing community of inventors

Foster, RI, United States of America

Lonn S Rider